A shortcut through process development for CAR-T cell manufacturing

Tuesday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST

Sponsor

A shortcut through process development for CAR-T cell manufacturing

For clinicians who want to start manufacturing CAR T cells, setting up a cell manufacturing process and QC system that can be transferred to GMP-compliant standards is extremely challenging. The development of a viable protocol is time-consuming and expensive, and translating protocols into SOPs is complicated, often resulting in further delays and expenses.

Learn how the Cell Manufacturing Enabling Package (CMEP) can save you time on process development, allowing you to proceed to validation as soon as possible. Designed by experts, and tested through years of experience in the CliniMACS Prodigy^® cell manufacturing facility, it has been developed to accelerate your path toward clinical manufacturing. Complementing this, a matching protocol for establishing flow-based QC of CAR T cells using the MACSQuant^® Analyzer has also been developed. Join the webinar to learn more about how you can benefit from these new developments.

Overcome common issues faced in CAR T cell manufacturing
Establish methods for flow-based QC of CAR T cells
Understand the steps following the CMEP

Marko Gogala

Product Manager for Services, Miltenyi Biotec

Dr. Marko Gogala is an experienced product manager in the biotech industry specializing in lab automation and biomanufacturing processes. In his current role, he is responsible for Miltenyi Services in the area of Cell Culture and Processing, where he collaborates with expert teams that plan, design and deploy customized applications and trainings to optimize, automate and scale up cell manufacturing. He has a Ph.D. from the Ludwig Maximilian University of Munich